FI931109A0 - Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virus - Google Patents
Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virusInfo
- Publication number
- FI931109A0 FI931109A0 FI931109A FI931109A FI931109A0 FI 931109 A0 FI931109 A0 FI 931109A0 FI 931109 A FI931109 A FI 931109A FI 931109 A FI931109 A FI 931109A FI 931109 A0 FI931109 A0 FI 931109A0
- Authority
- FI
- Finland
- Prior art keywords
- epstein
- ebv
- barr virus
- antibodies
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92200721 | 1992-03-13 | ||
EP92200721 | 1992-03-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI931109A0 true FI931109A0 (fi) | 1993-03-12 |
FI931109A FI931109A (fi) | 1993-09-14 |
FI114802B FI114802B (fi) | 2004-12-31 |
Family
ID=8210477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI931109A FI114802B (fi) | 1992-03-13 | 1993-03-12 | Epstein-Barr-virukseen liittyviä peptidejä ja nukleiinihapposekvenssejä |
Country Status (13)
Country | Link |
---|---|
US (1) | US5424398A (fi) |
EP (2) | EP1225226B1 (fi) |
JP (3) | JP4135996B2 (fi) |
KR (1) | KR100291247B1 (fi) |
AT (2) | ATE222291T1 (fi) |
AU (1) | AU666920B2 (fi) |
CA (1) | CA2092680C (fi) |
DE (2) | DE69334191T2 (fi) |
DK (2) | DK1225226T3 (fi) |
ES (2) | ES2184735T3 (fi) |
FI (1) | FI114802B (fi) |
PT (1) | PT574048E (fi) |
ZA (1) | ZA931797B (fi) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0726315B1 (en) * | 1993-07-23 | 2001-10-17 | Hans Prof. Dr. Wolf | Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
DE69432043T2 (de) * | 1993-09-14 | 2003-10-09 | Biomerieux B.V., Boxtel | Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV |
US5834747A (en) | 1994-11-04 | 1998-11-10 | Pixel Instruments | Universal credit card apparatus and method |
DE19526384C2 (de) * | 1995-07-19 | 1997-07-10 | Biotest Ag | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern |
US5813500A (en) * | 1996-03-25 | 1998-09-29 | Tenneco Automotive Inc. | Anti-swish mechanism for a damper |
FR2765688B1 (fr) | 1997-07-04 | 1999-09-10 | Pasteur Institut | Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications |
US7105496B2 (en) * | 1998-07-23 | 2006-09-12 | Northwestern University | Methods and compositions for inhibiting angiogenesis |
US6797691B1 (en) * | 1997-07-23 | 2004-09-28 | Northwestern University | Methods and compositions for inhibiting angiogenesis |
WO1999018126A1 (fr) * | 1997-10-07 | 1999-04-15 | Ono Pharmaceutical Co., Ltd. | POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION |
DE69940770D1 (de) | 1998-03-04 | 2009-06-04 | Biomerieux Bv | Vervielfältigung und nachweis von ebv barf1 zur diagnose von nasopharyngealen karzinom |
US20030064917A1 (en) * | 1998-07-23 | 2003-04-03 | Crawford Susan E. | Methods and compositions for inhibiting angiogenesis |
US6159950A (en) * | 1998-10-16 | 2000-12-12 | Cornell Research Foundation, Inc. | Method of modulating hair growth |
JP4981229B2 (ja) * | 2000-02-25 | 2012-07-18 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法 |
WO2003033520A2 (en) * | 2001-09-24 | 2003-04-24 | University Of Pittburgh Of The Commonwealth System Of Higher Education | Anticancer vaccine and diganostic methods and reagents |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
US20050063947A1 (en) * | 2002-03-27 | 2005-03-24 | Patrick Hwu | Method for treating cancer in humans |
US7226755B1 (en) * | 2002-09-25 | 2007-06-05 | The Procter & Gamble Company | HPTPbeta as a target in treatment of angiogenesis mediated disorders |
US7507568B2 (en) * | 2002-09-25 | 2009-03-24 | The Proctor & Gamble Company | Three dimensional coordinates of HPTPbeta |
US6886670B2 (en) * | 2003-09-29 | 2005-05-03 | Tenneco Automotive Operating Company Inc. | Extra support land for valve disc |
DE10307517A1 (de) * | 2003-02-21 | 2004-09-02 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung |
US6899207B2 (en) | 2003-09-29 | 2005-05-31 | Tenneco Automotive Operating Company Inc. | Extra support area for valve disc |
EP1781826A4 (en) * | 2004-06-12 | 2009-04-29 | Univ Oregon Health & Science | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ORTHOPOXVIRUS |
US7278987B2 (en) * | 2004-07-09 | 2007-10-09 | Anthony Solazzo | Ergonomic urological catheterization/irrigation tray |
WO2007044033A2 (en) | 2004-12-07 | 2007-04-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen |
EP2314349B1 (en) | 2005-12-01 | 2016-03-09 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Anti-viral griffithsin compounds, compositions, and methods of use |
EP2172210A1 (en) | 2005-12-23 | 2010-04-07 | Partnership&Corp. Technology Transfer | Synthetic peptides for use as inhibitors of neurotransmitter secretion |
US7868228B2 (en) | 2006-01-31 | 2011-01-11 | Monsanto Technology Llc | Phosphopantetheinyl transferases from bacteria |
BRPI0710645A2 (pt) | 2006-04-07 | 2012-03-20 | The Procter & Gamble Company | Anticorpos que se ligam à proteína humana tirosina fosfatase beta (hptpbeta) e usos dos mesmos |
US7795444B2 (en) * | 2006-06-27 | 2010-09-14 | Warner Chilcott Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US7589212B2 (en) * | 2006-06-27 | 2009-09-15 | Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US8846685B2 (en) | 2006-06-27 | 2014-09-30 | Aerpio Therapeutics Inc. | Human protein tyrosine phosphatase inhibitors and methods of use |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
WO2009158432A2 (en) | 2008-06-27 | 2009-12-30 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
WO2010011994A2 (en) | 2008-07-25 | 2010-01-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Polypeptides and uses thereof |
CA2737595C (en) | 2008-10-14 | 2017-09-12 | Monsanto Technology Llc | Utilization of fatty acid desaturases from hemiselmis spp. |
US9096555B2 (en) | 2009-01-12 | 2015-08-04 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome |
MY160399A (en) | 2009-07-06 | 2017-03-15 | Aerpio Therapeutics Inc | Compounds, compositions, and methods for preventing metastasis of cancer cells |
US8883832B2 (en) | 2009-07-06 | 2014-11-11 | Aerpio Therapeutics Inc. | Compounds, compositions, and methods for preventing metastasis of cancer cells |
US20120100166A1 (en) | 2010-07-15 | 2012-04-26 | Zyngenia, Inc. | Ang-2 Binding Complexes and Uses Thereof |
EP2673297A2 (en) | 2011-02-11 | 2013-12-18 | Zyngenia, Inc. | Monovalent and multivalent multispecific complexes and uses thereof |
CA2837169C (en) | 2011-05-24 | 2021-11-09 | Zyngenia, Inc. | Multispecific complexes comprising angiopoietin-2-binding peptide and their uses |
EP3348575A1 (en) | 2011-08-16 | 2018-07-18 | Emory University | Jaml specific binding agents, antibodies, and uses related thereto |
WO2013056240A1 (en) | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome and cancer |
BR112015023752B1 (pt) | 2013-03-15 | 2023-11-14 | Zyngenia, Inc. | Domínio de reconhecimento modular (mrd), complexo compreendendo mrd e cetuximabe, usos do complexo para inibir a angiogênese e tratar câncer e composição farmacêutica compreendendo o dito complexo |
EP2813849A1 (en) * | 2013-06-10 | 2014-12-17 | Charité-Universitätsmedizin Berlin (Charité) | EBV-specific immune signature as diagnostic markers in Chronic Fatigue Syndrome (CFS) |
AU2015204680B2 (en) | 2014-01-09 | 2019-07-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-viral cnidarins |
WO2016130628A1 (en) | 2015-02-10 | 2016-08-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Griffithsin mutants |
WO2016130899A1 (en) | 2015-02-13 | 2016-08-18 | The Board Of Trustees Of The University Of Illinois | Peptide inhibition of ccr3-mediated diseases or conditions |
WO2016201503A1 (en) | 2015-06-15 | 2016-12-22 | Monash University | Il-37 variants |
WO2017070744A1 (en) | 2015-10-30 | 2017-05-04 | Monash University | Methods and compositions for improving glucose metabolism |
CN108490177B (zh) * | 2018-02-08 | 2020-12-29 | 深圳市新产业生物医学工程股份有限公司 | 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒 |
EP4003393A1 (en) | 2019-07-29 | 2022-06-01 | The Board Of Trustees Of The University Of Illinois | Composition and method for promoting wound healing |
EP4077363A1 (en) | 2019-12-20 | 2022-10-26 | F. Hoffmann-La Roche AG | Il-37 fusion proteins and uses thereof |
US20240002445A1 (en) | 2020-11-18 | 2024-01-04 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Tyrosyl-lock peptides |
WO2023192802A1 (en) | 2022-04-01 | 2023-10-05 | The Board Of Trustees Of The University Of Illinois | Notch1 and notch4 decoys and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0291636A1 (en) * | 1983-11-07 | 1988-11-23 | The Wistar Institute | Immune response to viruses induced by anti-idiotype antibodies |
US4699880A (en) * | 1984-09-25 | 1987-10-13 | Immunomedics, Inc. | Method of producing monoclonal anti-idiotype antibody |
IE873041L (en) * | 1987-11-11 | 1989-05-11 | Ailbe Brennan | Viral antigens, diagnostic assay therefor and vaccines¹containing them |
WO1991002091A1 (en) * | 1989-08-10 | 1991-02-21 | Northwestern University | Method of identifying herpesviruses and oligonucleotides for use therein |
EP0585216A1 (en) * | 1989-11-24 | 1994-03-09 | The Council Of The Queensland Institue Of Medical Research | Im peptides |
PH31669A (en) * | 1989-12-20 | 1999-01-18 | Schering Corp | Bcrf1 proteins as inhibitors of interferon-gamma. |
JPH04310861A (ja) * | 1991-04-09 | 1992-11-02 | Kazuo Yanagi | 抗ebna抗体の測定方法および抗ebna抗体測定キット |
-
1993
- 1993-03-10 DE DE69334191T patent/DE69334191T2/de not_active Expired - Lifetime
- 1993-03-10 PT PT93200691T patent/PT574048E/pt unknown
- 1993-03-10 EP EP02075193A patent/EP1225226B1/en not_active Expired - Lifetime
- 1993-03-10 ES ES93200691T patent/ES2184735T3/es not_active Expired - Lifetime
- 1993-03-10 DE DE69332197T patent/DE69332197T2/de not_active Expired - Lifetime
- 1993-03-10 AT AT93200691T patent/ATE222291T1/de not_active IP Right Cessation
- 1993-03-10 DK DK02075193T patent/DK1225226T3/da active
- 1993-03-10 EP EP93200691A patent/EP0574048B1/en not_active Expired - Lifetime
- 1993-03-10 ES ES02075193T patent/ES2298325T3/es not_active Expired - Lifetime
- 1993-03-10 AT AT02075193T patent/ATE380243T1/de not_active IP Right Cessation
- 1993-03-10 DK DK93200691T patent/DK0574048T3/da active
- 1993-03-12 FI FI931109A patent/FI114802B/fi not_active IP Right Cessation
- 1993-03-12 CA CA002092680A patent/CA2092680C/en not_active Expired - Lifetime
- 1993-03-12 ZA ZA931797A patent/ZA931797B/xx unknown
- 1993-03-12 AU AU35152/93A patent/AU666920B2/en not_active Expired
- 1993-03-12 US US08/031,148 patent/US5424398A/en not_active Expired - Lifetime
- 1993-03-13 KR KR1019930003940A patent/KR100291247B1/ko not_active IP Right Cessation
- 1993-03-15 JP JP08009993A patent/JP4135996B2/ja not_active Expired - Lifetime
-
2004
- 2004-03-31 JP JP2004102197A patent/JP4106041B2/ja not_active Expired - Lifetime
-
2008
- 2008-03-31 JP JP2008089543A patent/JP4365440B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
PT574048E (pt) | 2002-12-31 |
JP4106041B2 (ja) | 2008-06-25 |
AU666920B2 (en) | 1996-02-29 |
JP2004261183A (ja) | 2004-09-24 |
ES2184735T3 (es) | 2003-04-16 |
FI114802B (fi) | 2004-12-31 |
CA2092680C (en) | 2006-08-08 |
JP4365440B2 (ja) | 2009-11-18 |
ATE380243T1 (de) | 2007-12-15 |
ZA931797B (en) | 1993-09-30 |
ES2298325T3 (es) | 2008-05-16 |
DK0574048T3 (da) | 2002-12-16 |
EP1225226A1 (en) | 2002-07-24 |
DE69332197T2 (de) | 2003-04-17 |
ATE222291T1 (de) | 2002-08-15 |
DK1225226T3 (da) | 2008-04-14 |
JPH0690787A (ja) | 1994-04-05 |
AU3515293A (en) | 1993-09-16 |
JP2008261851A (ja) | 2008-10-30 |
JP4135996B2 (ja) | 2008-08-20 |
CA2092680A1 (en) | 1993-09-14 |
KR930019829A (ko) | 1993-10-19 |
KR100291247B1 (ko) | 2001-06-01 |
FI931109A (fi) | 1993-09-14 |
DE69332197D1 (de) | 2002-09-19 |
EP0574048A2 (en) | 1993-12-15 |
EP1225226B1 (en) | 2007-12-05 |
US5424398A (en) | 1995-06-13 |
EP0574048B1 (en) | 2002-08-14 |
DE69334191T2 (de) | 2008-11-27 |
DE69334191D1 (de) | 2008-01-17 |
EP0574048A3 (fi) | 1994-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI931109A0 (fi) | Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virus | |
TW279178B (fi) | ||
PT102022A (pt) | Processo para a producao e purificacao de astaloglicoprotetinas adequadas para uso em vacinas e conjunto de materiais de ensaio para detectar a sua presenca | |
HUT73098A (en) | Hepatitis c virus (hcv) polypeptides | |
AU8700291A (en) | Hcv-specific peptides, agents therefor and the use thereof | |
EP0151079A3 (en) | Vaccine against epstein-barr virus | |
AU571128B2 (en) | Expression of immunologically reactive aids viral protein | |
CA2057052A1 (en) | Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof | |
AU1814692A (en) | Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto | |
DK326289A (da) | Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden | |
DK498387A (da) | Virus-dna-sekvens | |
CA2084521A1 (en) | Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method | |
EP0754755A3 (de) | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern | |
Bopp et al. | Comparative studies on novel protein antigens of streptococci of the serological group B | |
FI910587A0 (fi) | Syntetiska polypeptider och antikroppar, vilka haenfoer sig till epstein-barr-virusets nukleaera antigen. | |
Greenham et al. | Application of potassium thiocyanate as a destaining agent for confirming the specificity of viral immunofluorescence | |
RU98119633A (ru) | Способ получения полипептида, обладающего антигенной активностью вируса гепатита е. набор для определения антител к возбудителю гепатита е - вирусу гепатита е |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |